Literature DB >> 34363547

Serum sodium level associated with coronary artery lesions in patients with Kawasaki disease.

Hiroya Masuda1,2, Ryusuke Ae3, Taka-Aki Koshimizu4, Masami Matsumura2, Koki Kosami1, Kanako Hayashida1,2, Nobuko Makino1, Yuri Matsubara1, Teppei Sasahara1, Yosikazu Nakamura1.   

Abstract

INTRODUCTION/
OBJECTIVES: Hyponatremia is a potential risk factor for the development of coronary artery lesions (CALs) identified after acute Kawasaki disease (KD). However, the serum sodium distribution corresponding to the reference intervals differs between infants (< 1 year of age) and older children. We hypothesized the association of serum sodium level with CAL complications differs between infants and older patients with KD.
METHODS: We analyzed 21,610 population-based patients who developed KD throughout Japan during 2013-2014. We performed multivariable logistic regression analyses to evaluate the association between serum sodium and CAL complications. Additionally, we stratified the serum sodium distribution associated with CAL complications by infants and older patients.
RESULTS: CALs were identified in 158 (3.6%) infants and 302 (1.8%) older patients. Infants were more likely to develop CALs when within the normal sodium range compared with older patients (75% vs. 29%), whereas most older patients developed CALs with a sodium level lower than the reference interval. Serum sodium ≤ 130 mEq/L indicated significantly higher risk for development of CALs in both groups (adjusted odds ratio [95% confidence intervals] = 3.21 [1.65-6.25] in infants and 1.74 [1.18-2.57] in older patients).
CONCLUSIONS: Serum sodium distribution associated with CAL complications differed greatly between infants and older patients. Older patients developed CALs with sodium levels lower than the reference interval; however, among infants, hyponatremia was not necessarily a risk factor for developing coronary artery lesion. When considering risk assessments for CALs using serum sodium levels, infants with KD should be distinguished from older patients. Key Points • Hyponatremia is a potential risk factor for the development of coronary artery lesions (CALs) among patients with Kawasaki disease. • However, the serum sodium distribution corresponding to the reference intervals differs between infants (< 1 year of age) and older children. • Most infants developed CALs within the normal sodium range, whereas older patients developed at a range lower than the reference interval. • These findings highlight that when considering risk assessments for CALs using serum sodium levels, infants should be distinguished from older patients.
© 2021. International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Coronary artery disease; Coronary artery lesion; Kawasaki disease; Serum sodium

Mesh:

Substances:

Year:  2021        PMID: 34363547     DOI: 10.1007/s10067-021-05881-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  38 in total

1.  Indicators of unresponsiveness after initial i.v. immunoglobulin treatment in acute Kawasaki disease.

Authors:  Ikuo Hashimoto
Journal:  Pediatr Int       Date:  2019-07-11       Impact factor: 1.524

2.  Outcomes in Kawasaki disease patients with coronary artery abnormalities at admission.

Authors:  Ryusuke Ae; Joseph Y Abrams; Ryan A Maddox; Lawrence B Schonberger; Yosikazu Nakamura; Masanari Kuwabara; Nobuko Makino; Yuri Matsubara; Daisuke Matsubara; Koki Kosami; Teppei Sasahara; Ermias D Belay
Journal:  Am Heart J       Date:  2020-05-03       Impact factor: 4.749

3.  Hyponatremia in Kawasaki disease.

Authors:  Toru Watanabe; Yuki Abe; Seiichi Sato; Yumiko Uehara; Kanju Ikeno; Tokinari Abe
Journal:  Pediatr Nephrol       Date:  2006-03-25       Impact factor: 3.714

4.  Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018.

Authors:  Ryusuke Ae; Nobuko Makino; Koki Kosami; Masanari Kuwabara; Yuri Matsubara; Yosikazu Nakamura
Journal:  J Pediatr       Date:  2020-05-23       Impact factor: 4.406

Review 5.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

6.  A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.

Authors:  J W Newburger; M Takahashi; A S Beiser; J C Burns; J Bastian; K J Chung; S D Colan; C E Duffy; D R Fulton; M P Glode
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

7.  Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.

Authors:  Ritei Uehara; Ermias D Belay; Ryan A Maddox; Robert C Holman; Yosikazu Nakamura; Mayumi Yashiro; Izumi Oki; Hirotaro Ogino; Lawrence B Schonberger; Hiroshi Yanagawa
Journal:  Pediatr Infect Dis J       Date:  2008-02       Impact factor: 2.129

8.  Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group.

Authors:  Elisa Fernandez-Cooke; Ana Barrios Tascón; Judith Sánchez-Manubens; Jordi Antón; Carlos Daniel Grasa Lozano; Javier Aracil Santos; Enrique Villalobos Pinto; Daniel Clemente Garulo; Beatriz Mercader Rodríguez; Matilde Bustillo Alonso; Esmeralda Nuñez Cuadros; Maria Luisa Navarro Gómez; Sara Domínguez-Rodríguez; Cristina Calvo
Journal:  PLoS One       Date:  2019-05-20       Impact factor: 3.240

9.  A new model for predicting intravenous immunoglobin-resistant Kawasaki disease in Chongqing: a retrospective study on 5277 patients.

Authors:  Xu-Hai Tan; Xiao-Wei Zhang; Xiao-Yun Wang; Xiang-Qian He; Chu Fan; Tie-Wei Lyu; Jie Tian
Journal:  Sci Rep       Date:  2019-02-11       Impact factor: 4.379

10.  A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old.

Authors:  Shu Wu; Yuan Long; Selena Chen; Yaqian Huang; Ying Liao; Yan Sun; Qingyou Zhang; Chunyu Zhang; Hui Yan; Jianguang Qi; Xueqin Liu; Yonghong Chen; Yong Zhang; Junbao Du
Journal:  Front Pediatr       Date:  2019-12-11       Impact factor: 3.418

View more
  3 in total

1.  [Association between duration of fever before treatment and intravenous immunoglobulin resistance in Kawasaki disease].

Authors:  Xin Wang; Si-Lin Pan; Zhan-Hui DU; Zhi-Xian Ji; Gang Luo; Hong-Xiao Sun; Shu-Jing Ma
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-04-15

2.  Serum alanine aminotransferase level and intravenous immunoglobulin resistance in patients with kawasaki disease.

Authors:  Hiroya Masuda; Ryusuke Ae; Taka-Aki Koshimizu; Koki Kosami; Nobuko Makino; Yuri Matsubara; Teppei Sasahara; Yosikazu Nakamura
Journal:  Clin Rheumatol       Date:  2022-07-07       Impact factor: 3.650

3.  Risk factors and coronary artery outcomes of coronary artery aneurysms differing in size and emergence time in children with Kawasaki disease.

Authors:  Jie Liu; Qiaoyu Yue; Suyuan Qin; Danyan Su; Bingbing Ye; Yusheng Pang
Journal:  Front Cardiovasc Med       Date:  2022-09-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.